ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

ACD Asks Senate To Raise Budget Of CDC Cancer Programs

July 30, 1993

Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed

June 11, 1982

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013

National Cancer Act: Early Promises Were Overstated

May 15, 1998

Post Reporter Responds To Criticism Of Cancer Series

January 1, 1982